Biological therapies and management of oral mucosal disease.

Br Dent J

Consultant/Assistant Professor in Oral Medicine, Dublin Dental University Hospital, School of Dental Science, Trinity College Dublin, Ireland.

Published: February 2024

Biologic drugs are drugs made by living organisms and the term is usually limited to monoclonal antibodies or receptors targeting specific cytokines or cells that have been developed in recent decades. These drugs have had an enormous impact on the management of cancers, including head and neck cancers, and immune-mediated inflammatory conditions, for example, rheumatoid arthritis and inflammatory bowel disease. General dental practitioners will routinely be managing patients who are on these medications for a wide range of systemic conditions. These drugs also have a limited role in the management of immune-mediated oral mucosal disease. In this article, we will introduce the range of biological agents and their systemic indications and then elaborate on their use in oral mucosal disease and the disadvantages associated with their use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10883882PMC
http://dx.doi.org/10.1038/s41415-024-7065-9DOI Listing

Publication Analysis

Top Keywords

oral mucosal
12
mucosal disease
12
biological therapies
4
therapies management
4
management oral
4
disease
4
disease biologic
4
drugs
4
biologic drugs
4
drugs drugs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!